Business ❯Finance ❯Stock Market ❯Company Performance

Novo Nordisk

FDA Declares Semaglutide Shortage Over, Impacting Compounded Drug Market

Novo Nordisk Reports Doubling Wegovy Sales, Projects Slower Growth in 2025

Novo Nordisk Shares Plunge After Weight-Loss Drug Trial Falls Short

Novo Nordisk Expands Wegovy Supply Amid Compounding Drug Concerns

Eli Lilly's Q2 Earnings Surge on High Demand for Weight-Loss Drugs